The EU has said it plans to roll out over a six-month period a new Entry/Exit System, dubbed EES, that will require the ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies.1 Icotrokinra also showed ...

More than 260,000 California second graders are starting the school year with more than pencils and backpacks—they’re also receiving their first college savings scholarship through CalKIDS, the state ...

If you want to enjoy the many arts and cultural opportunities in the region for free, the Allegheny Regional Asset District ...

The British government has confirmed plans to introduce a nationwide digital identification system, a move Prime Minister ...

The Pentagon said it would forbid reporters from gathering any information that had not been authorized for release, and ...

The Food and Drug Administration (FDA) has expanded the approval of Evkeeza ® (evinacumab-dgnb) to include children aged 1 year and older with homozygous familial hypercholesterolemia (HoFH).

Recently FDA-cleared, adaptive deep brain stimulation is gaining global traction, offering real-time, personalized therapy ...

The Food and Drug Administration (FDA) has issued another Complete Response Letter (CRL) to Regeneron for the Biologics License Application (BLA) for odronextamab in relapsed/refractory follicular ...

Deputy Minister of Economy, Environment, and Agriculture of Ukraine, Denys Bashlyk, met with a delegation from the UN World ...

Ukrainian President Volodymyr Zelensky and NATO Secretary General Mark Rutte discussed the effectiveness and further expansion of the PURL initiative. — Ukrinform.

The Food and Drug Administration (FDA) has approved Palsonify ™ (paltusotine) for the treatment of adults with acromegaly who had an inadequate response to surgery and/or for whom surgery is not an ...